ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Now Accepting Applications for Eric Dostie Memorial College Scholarship

TEMECULA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises Inc., is now accepting applications for its 28th annual Eric Dostie Memorial College Scholarship. Ten awards of $1,000 each will be granted to qualifying students who can best demonstrate scholastic achievement, community service and financial need.

The scholarship was created to honor the memory of Eric Dostie, a 5-year-old boy with hemophilia who was tragically murdered on August 27, 1994, due to the high cost of his healthcare. Awards will provide financial assistance to students who either have hemophilia or von Willebrand disease, or who have a family member with hemophilia or von Willebrand disease. Applicants must be United States citizens, live in the United States, and be enrolled full-time in an accredited two- or four-year college program in the United States.

“Since its inception 28 years ago, the Eric Dostie Memorial Scholarship has helped 280 students pursue their dreams of higher education,” said Patrick M. Schmidt, chief executive officer at FFF Enterprises Inc. “At FFF, we understand the financial impact a bleeding disorder can have on individuals and their families. This scholarship is about ensuring a quality higher education remains within financial reach for these bright, talented young people.”

Scholarship applicants must submit a 400-word essay describing their motivation for pursuing higher education, their area of study, obstacles they have had to overcome, and how they plan to use their education to benefit and enrich humankind. 

Congratulations to our 2022 Eric Dostie Memorial College Scholarship recipients:

  • Andrew Morrison
  • Blake Skipworth
  • Caitlyn Myers
  • Christopher Ambrosio
  • Eliana Horowitz
  • James Cosman
  • Lily Tignor
  • Nathan Stone
  • Nicholas Leach
  • Rebecca Cox

The deadline to submit applications is March 1, 2023. Recipients will be contacted in June 2023. Visit the Nufactor Eric Dostie Memorial College Scholarship website to learn more about the program and to complete the application.

About Nufactor, Inc.

Nufactor, Inc. is a specialty infusion company and subsidiary of FFF Enterprises Inc., the largest and most trusted specialty pharmaceutical distributor. Established in 1995, Nufactor offers safe, convenient, and reliable home infusion solutions for patients receiving immunoglobulin, antihemophilic factor, and infliximab. Nufactor has earned The Joint Commission’s Gold Seal of Approval® and URAC’s Specialty Pharmacy Accreditation.

Please visit Nufactor.com as well as LinkedIn, Instagram, Facebook and YouTube for more information about the company.

 About FFF Enterprises Inc.

Founded in 1988, FFF Enterprises Inc. is a privately held, multibillion-dollar specialty pharmaceutical distributor specializing in plasma products, rare and orphan drugs, and vaccines. FFF Enterprises is the parent company to leading specialty infusion pharmacy Nufactor, Inc., as well as InCircle, LLC and RightNow Inventory™. Our partners include global pharmaceutical and biologics manufacturers, prestigious healthcare systems, large and independent retail pharmacies, and leading alternate care sites. Our nationwide commerce is supported by a network of distribution and infusion pharmacy locations utilizing world-class technology and cybersecurity solutions.

Please visit FFF Enterprises.com, as well as LinkedIn, Twitter, Facebook and YouTube for more information about the company.

Attachment


Michelle Valenzuela
FFF Enterprises.com
(951) 296-2528 ext. 1410
mvalenzuela@fffenterprises.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.